Giaccia A - Search Results

1

Comment on: osteopontin as toxic marker.

Le QT, Cao H, Koong A, Giaccia A. Le QT, et al. Among authors: giaccia a. Radiother Oncol. 2006 Feb;78(2):230; author reply 230-1. doi: 10.1016/j.radonc.2005.12.011. Epub 2006 Jan 26. Radiother Oncol. 2006. PMID: 16442647 No abstract available.

2

Identification of osteopontin as a prognostic plasma marker for head and neck squamous cell carcinomas.

Le QT, Sutphin PD, Raychaudhuri S, Yu SC, Terris DJ, Lin HS, Lum B, Pinto HA, Koong AC, Giaccia AJ. Le QT, et al. Among authors: giaccia aj. Clin Cancer Res. 2003 Jan;9(1):59-67. Clin Cancer Res. 2003. PMID: 12538452

3

Plasma osteopontin is an independent prognostic marker for head and neck cancers.

Petrik D, Lavori PW, Cao H, Zhu Y, Wong P, Christofferson E, Kaplan MJ, Pinto HA, Sutphin P, Koong AC, Giaccia AJ, Le QT. Petrik D, et al. Among authors: giaccia aj. J Clin Oncol. 2006 Nov 20;24(33):5291-7. doi: 10.1200/JCO.2006.06.8627. J Clin Oncol. 2006. PMID: 17114663

4

The RGD domain of human osteopontin promotes tumor growth and metastasis through activation of survival pathways.

Courter D, Cao H, Kwok S, Kong C, Banh A, Kuo P, Bouley DM, Vice C, Brustugun OT, Denko NC, Koong AC, Giaccia A, Le QT. Courter D, et al. Among authors: giaccia a. PLoS One. 2010 Mar 10;5(3):e9633. doi: 10.1371/journal.pone.0009633. PLoS One. 2010. PMID: 20224789 Free PMC article.

5

Hypoxia upregulates osteopontin expression in NIH-3T3 cells via a Ras-activated enhancer.

Zhu Y, Denhardt DT, Cao H, Sutphin PD, Koong AC, Giaccia AJ, Le QT. Zhu Y, et al. Oncogene. 2005 Sep 29;24(43):6555-63. doi: 10.1038/sj.onc.1208800. Oncogene. 2005. PMID: 16007184

6

Galectin-1: a link between tumor hypoxia and tumor immune privilege.

Le QT, Shi G, Cao H, Nelson DW, Wang Y, Chen EY, Zhao S, Kong C, Richardson D, O'Byrne KJ, Giaccia AJ, Koong AC. Le QT, et al. J Clin Oncol. 2005 Dec 10;23(35):8932-41. doi: 10.1200/JCO.2005.02.0206. Epub 2005 Oct 11. J Clin Oncol. 2005. PMID: 16219933

7

A noninvasive approach for assessing tumor hypoxia in xenografts: developing a urinary marker for hypoxia.

Nelson DW, Cao H, Zhu Y, Sunar-Reeder B, Choi CY, Faix JD, Brown JM, Koong AC, Giaccia AJ, Le QT. Nelson DW, et al. Cancer Res. 2005 Jul 15;65(14):6151-8. doi: 10.1158/0008-5472.CAN-04-2602. Cancer Res. 2005. PMID: 16024616

8

An evaluation of tumor oxygenation and gene expression in patients with early stage non-small cell lung cancers.

Le QT, Chen E, Salim A, Cao H, Kong CS, Whyte R, Donington J, Cannon W, Wakelee H, Tibshirani R, Mitchell JD, Richardson D, O'Byrne KJ, Koong AC, Giaccia AJ. Le QT, et al. Among authors: giaccia aj. Clin Cancer Res. 2006 Mar 1;12(5):1507-14. doi: 10.1158/1078-0432.CCR-05-2049. Clin Cancer Res. 2006. PMID: 16533775 Free article.

9

Expression and prognostic significance of a panel of tissue hypoxia markers in head-and-neck squamous cell carcinomas.

Le QT, Kong C, Lavori PW, O'byrne K, Erler JT, Huang X, Chen Y, Cao H, Tibshirani R, Denko N, Giaccia AJ, Koong AC. Le QT, et al. Int J Radiat Oncol Biol Phys. 2007 Sep 1;69(1):167-75. doi: 10.1016/j.ijrobp.2007.01.071. Int J Radiat Oncol Biol Phys. 2007. PMID: 17707270

10

Prognostic significance of plasma osteopontin in patients with locoregionally advanced head and neck squamous cell carcinoma treated on TROG 02.02 phase III trial.

Lim AM, Rischin D, Fisher R, Cao H, Kwok K, Truong D, McArthur GA, Young RJ, Giaccia A, Peters L, Le QT. Lim AM, et al. Among authors: giaccia a. Clin Cancer Res. 2012 Jan 1;18(1):301-7. doi: 10.1158/1078-0432.CCR-11-2295. Epub 2011 Nov 17. Clin Cancer Res. 2012. PMID: 22096023 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

351 results

Search Page

Filters